Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Agilon Health

Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022

Upgrades

Benzinga

Agilon Health's Return On Capital Employed Overview

Benzinga Pro data, Agilon Health (NYSE:AGL) reported Q4 sales of $462.89 million. Earnings fell to a loss of $56.74 million, resulting in a 57.79% decrease from last quarter.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.